{"podcast":{"title":"DX Today | No-Hype Podcast & News About AI & DX","slug":"dx-today-no-hype-podcast-news-about-ai-dx-6434212","podcast_index_feed_id":6434212,"rss_url":"https://rss.buzzsprout.com/2207817.rss","website_url":"https://dxtoday.com/free-dxt-podcast","image_url":"https://storage.buzzsprout.com/dwohat9h5b61o3j3b9bhs8v3q3f1?.jpg","author":"Rick Spair","episode_count":780,"summary":"The DX Today Podcast: Real Insights About AI and Digital Transformation Tired of AI hype and transformation snake oil? This isn't another sales pitch disguised as expertise. Join a 30+ year tech veteran and Chief AI Officer who's built $1.2 billion in real solutions—and has the battle scars to prove it. No vendor agenda. No sponsored content. Just unfiltered insights about what actually works in AI and digital transformation, what spectacularly fails, and why most \"expert\" advice misses the mark. If you're looking for honest perspectives from someone who's been in the trenches since before \"digital transformation\" was a buzzword, you've found your show. Real problems, real solutions, real talk. For executives, practitioners, and anyone who wants the truth about technology without the sales pitch.","last_synced_at":"2026-09-24T10:19:19.051595+00:00","page_url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212"},"episode":{"title":"AI Designed Drugs Face Their Reckoning: Isomorphic Labs, Insilico's Phase 3, and Medicine's Make or Break Year - July 20, 2026","slug":"ai-designed-drugs-face-their-reckoning-isomorphic-labs-insilico-s-phase-3-and-medicine-s-make-or-break-year-july-20-2026","published_at":"2026-07-20T10:15:07+00:00","page_url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/ai-designed-drugs-face-their-reckoning-isomorphic-labs-insilico-s-phase-3-and-medicine-s-make-or-break-year-july-20-2026","show_page_url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212","url":"https://www.buzzsprout.com/2207817/episodes/19518481-ai-designed-drugs-face-their-reckoning-isomorphic-labs-insilico-s-phase-3-and-medicine-s-make-or-break-year-july-20-2026.mp3","audio_url":"https://www.buzzsprout.com/2207817/episodes/19518481-ai-designed-drugs-face-their-reckoning-isomorphic-labs-insilico-s-phase-3-and-medicine-s-make-or-break-year-july-20-2026.mp3","summary":"AI Designed Drugs Face Their Reckoning: Isomorphic Labs, Insilico's Phase 3, and Medicine's Make or Break Year Two milestones just turned AI drug discovery from promise into a real world test. Isomorphic Labs, the Google DeepMind spinoff built on the AlphaFold lineage, is moving its first AI designed molecules into human oncology trials, while Insilico Medicine has pushed rentosertib, an AI discovered treatment for the lung disease idiopathic pulmonary fibrosis, into a pivotal Phase 3 study...","meta_description":"AI Designed Drugs Face Their Reckoning: Isomorphic Labs, Insilico's Phase 3, and Medicine's Make or Break Year Two milestones just turned AI drug discover…","key_points":[],"chapters":[],"topics":[],"duration_seconds":818,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/dx-today-no-hype-podcast-news-about-ai-dx-6434212/episodes/ai-designed-drugs-face-their-reckoning-isomorphic-labs-insilico-s-phase-3-and-medicine-s-make-or-break-year-july-20-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/ai-designed-drugs-face-their-reckoning-isomorphic-labs-insilico-s-phase-3-and-medicine-s-make-or-break-year-july-20-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}